123 related articles for article (PubMed ID: 23425264)
1. Mini Focus: bioanalysis of biosimilars.
Amaravadi L; Marini J
Bioanalysis; 2013 Mar; 5(5):515-6. PubMed ID: 23425264
[No Abstract] [Full Text] [Related]
2. European perspective on biosimilars.
Wadhwa M; Thorpe R
Bioanalysis; 2013 Mar; 5(5):521-4. PubMed ID: 23425266
[No Abstract] [Full Text] [Related]
3. Analytical and bioanalytical assay challenges to support comparability studies for biosimilar drug development.
Cai XY; Wake A; Gouty D
Bioanalysis; 2013 Mar; 5(5):517-20. PubMed ID: 23425265
[No Abstract] [Full Text] [Related]
4. Clinical development of biosimilars: an evolving landscape.
Subramanyam M
Bioanalysis; 2013 Mar; 5(5):575-86. PubMed ID: 23425273
[TBL] [Abstract][Full Text] [Related]
5. A wide angle view of biosimilars from a bioanalytical perspective.
Oldfield P
Bioanalysis; 2013 Mar; 5(5):533-5. PubMed ID: 23425269
[No Abstract] [Full Text] [Related]
6. Nonclinical development of a biosimilar: the current landscape.
O'Connor A; Rogge M
Bioanalysis; 2013 Mar; 5(5):537-44. PubMed ID: 23425270
[TBL] [Abstract][Full Text] [Related]
7. Biosimilars in rheumatology: the wind of change.
Schneider CK
Ann Rheum Dis; 2013 Mar; 72(3):315-8. PubMed ID: 23390018
[No Abstract] [Full Text] [Related]
8. Challenges in bioanalytical assays for biosimilars.
Wang X; Chen L
Bioanalysis; 2014 Aug; 6(16):2111-3. PubMed ID: 25331854
[No Abstract] [Full Text] [Related]
9. Biosimilars take center stage.
Adams KT
Manag Care; 2014 Apr; 23(4):44-6. PubMed ID: 24864533
[No Abstract] [Full Text] [Related]
10. A consistency approach for evaluation of biosimilar products.
Tsou HH; Chang WJ; Hwang WS; Lai YH
J Biopharm Stat; 2013; 23(5):1054-66. PubMed ID: 23957515
[TBL] [Abstract][Full Text] [Related]
11. Conference Report: Bioanalysis-related topics presented at the International Conference and Exhibition on Biowaivers and Biosimilars.
Colletti KS
Bioanalysis; 2013 Mar; 5(5):529-31. PubMed ID: 23425268
[TBL] [Abstract][Full Text] [Related]
12. Assessing biosimilarity and interchangeability of biosimilar products.
Chow SC
Stat Med; 2013 Feb; 32(3):361-3. PubMed ID: 23307569
[No Abstract] [Full Text] [Related]
13. The rise of the biosimilar.
McCamish M; Woollett G
Expert Rev Clin Pharmacol; 2012 Nov; 5(6):597-9. PubMed ID: 23234317
[No Abstract] [Full Text] [Related]
14. Scientific considerations for assessing biosimilar products.
Chow SC; Wang J; Endrenyi L; Lachenbruch PA
Stat Med; 2013 Feb; 32(3):370-81. PubMed ID: 22933240
[TBL] [Abstract][Full Text] [Related]
15. Conference report: 6th GCC focus on LBA: critical reagents, positive controls and reference standards; specificity for endogenous compounds; biomarkers; biosimilars.
Nicholson R; Lowes S; Caturla MC; Safavi A; Mamelak D; Islam R; Allinson J; Gouty D; Khan M; Lelacheur R; Shoup R; Martinez S; Dumont I; Zimmer J; Steffen R; Petrilla J; Awaiye K; Sheldon C; Turk D; Fast D; Kamerud J; Dinan A; Lin ZJ; Garofolo W; Tang D; Wright L; Lin J; Yamashita Y; Liu Y; Xu A; Hayes R; Bouhajib M; Levesque A; Gagnon-Carignan S; Harman J; Warren M; Karnik S; Cojocaru L; Reuschel S; Gonzalez P; Fatmi S; Vija J; Rock M; Malone M; Nowatzke W; Fang X
Bioanalysis; 2012 Oct; 4(19):2335-42. PubMed ID: 23088460
[No Abstract] [Full Text] [Related]
16. Differences in bioanalytical method validation for biologically derived macromolecules (biosimilars) compared with small molecules (generics).
Oldfield P
Bioanalysis; 2011 Jul; 3(14):1551-3. PubMed ID: 21756087
[No Abstract] [Full Text] [Related]
17. Analysis of biological therapeutic agents and biosimilars.
Phinney K
Anal Bioanal Chem; 2014 Oct; 406(26):6539. PubMed ID: 25190012
[No Abstract] [Full Text] [Related]
18. Biosimilars: the 'future' of biologic therapy?
Ranjan N; Mahajan VK; Misra M
J Dermatolog Treat; 2011 Dec; 22(6):319-22. PubMed ID: 20666673
[TBL] [Abstract][Full Text] [Related]
19. [Controversy on biosimilar drugs and their therapeutic exchange].
Dorantes Calderón B
Farm Hosp; 2009; 33(4):181-2. PubMed ID: 19712605
[No Abstract] [Full Text] [Related]
20. Non-inferiority versus equivalence clinical trials in assessing biological products.
Pinto VF
Sao Paulo Med J; 2011 May; 129(3):183-4. PubMed ID: 21755255
[No Abstract] [Full Text] [Related]
[Next] [New Search]
